Techniques of extracorporeal cytokine removal: a systematic review of human studies

References

• Beale R, Reinhart K, Brunkhorst F, Dobb G, Levy M, Martin G. Promoting global research excellence in severe sepsis (PROGRESS): lessons from an International Sepsis Registry. Infection. 2009;37:222–232
   PubMed Web of Science ®Google Scholar
• Cabre L, Mancebo J, Solsona JF, et al. Multicenter study of the multiple organ dysfunction syndrome in intensive care units: the usefulness of Sequential Organ Failure Assessment scores in decision making. Intensive Care Med. 2005;31:927–933
   PubMed Web of Science ®Google Scholar
• Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125–1128
   PubMed Web of Science ®Google Scholar
• Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 2009;37:291–304
   PubMed Web of Science ®Google Scholar
• Schefold JC, Hasper D, Jörres A. Organ crosstalk in critically ill patients: hemofiltration and immunomodulation in sepsis. Blood Purif. 2009;28:116–123
   Google Scholar
• Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artificial Organs. 2003;27:792–801
   PubMed Web of Science ®Google Scholar
• Fisher CJ Jr, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. J Am Med Assoc. 1994;271:1836–1843
   PubMed Web of Science ®Google Scholar
• Opal SM, Fisher CJ Jr, Dhainaut JF, et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, doubleblind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997;25:1115–1124
   PubMed Web of Science ®Google Scholar
• Kellum JA, Bellomo R, Mehta R, Ronco C. Blood purification in non-renal critical illness. Blood Purif. 2003;21:6–13
   PubMedGoogle Scholar
• Venkataraman R, Subramanian S, Kellum JA. Clinical review: extracorporeal blood purification in severe sepsis. Crit Care. 2003;7:139–145
   Web of Science ®Google Scholar
• Ronco C, Inguaggiato P, D'Intini V, et al. The role of extracorporeal therapies in sepsis. J Nephrol. 2003;16(Suppl 7):S34–S41
   Google Scholar
• Stadlbauer V, Krisper P, Aigner R, et al. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care. 2006;10:R169--R175
   PubMed Web of Science ®Google Scholar
• Morgera S, Haase M, Kuss T, et al. Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med. 2006;34:2099–2104
   PubMed Web of Science ®Google Scholar
• Peng Y, Yuan Z, Li H. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis. Burns. 2005;31:623–628
   PubMed Web of Science ®Google Scholar
• Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 2004;43:444–453
   PubMed Web of Science ®Google Scholar
• Morgera S, Rocktäschel J, Haase M, et al. Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med. 2003;29:1989–1995
   PubMed Web of Science ®Google Scholar
• Dahaba AA, Elawady GA, Rehak PH, List WF. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous hemofiltration in septic patients. Anaesth Intensive Care. 2002;30:269–274
   PubMed Web of Science ®Google Scholar
• Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med. 1998;26:1995–2000
   PubMed Web of Science ®Google Scholar
• Sanchez-Izquierdo JA, Perez Vela JL, Lozano Quintana MJ, Alted Lopez E, Ortuño de Solo B, Ambros Checa A. Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis. 1997;30:483–488
   Google Scholar
• Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med. 1997;23:878–884
   PubMed Web of Science ®Google Scholar
• van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Ren Fail. 1997;19:443–454
   Web of Science ®Google Scholar
• Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997;23:288–296
   PubMed Web of Science ®Google Scholar
• Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med. 1996;22:1360–1367
   PubMedGoogle Scholar
• Bellomo R, Tipping P, Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail. 1995;17:457–466
   PubMed Web of Science ®Google Scholar
• van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W. Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: a laboratory and clinical study. Contrib Nephrol. 1995;116:62–75
   PubMedGoogle Scholar
• Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993;21:522–526
   PubMed Web of Science ®Google Scholar
• Byrick RJ, Goldstein MB, Wong PY. Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arteriovenous hemodialysis. Crit Care Med. 1992;20:1483–1486
   Google Scholar
• Antunes N, Dragosavc D, Petrucci Junior O, et al. The use of ultrafiltration for inflammatory mediators removal during cardiopulmonary bypass in coronary artery bypass graf surgery. Rev Bras Cir Cardiovasc. 2008;23:175–182
   Google Scholar
• Brancaccio G, Villa E, Girolami E, et al. Inflammatory cytokines in pediatric cardiac surgery and variable effect of the hemofiltration process. Perfusion. 2005;20:263–268
   Google Scholar
• Berdat PA, Eichenberger E, Ebell J, et al. Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg. 2004;127:1688–1696
   Google Scholar
• Dittrich S, Aktuerk D, Seitz S, et al. Effects of ultrafiltration and peritoneal dialysis on proinflammatory cytokines during cardiopulmonary bypass surgery in newborns and infants. Eur J Cardiothorac Surg. 2004;25:935–940
   PubMed Web of Science ®Google Scholar
• Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002;30:1250–1255
   PubMed Web of Science ®Google Scholar
• Kiziltepe U, Uysalel A, Corapcioglu T, Dalva K, Akan H, Akalin H. Effects of combined conventional and modified ultrafiltration in adult patients. Ann Thorac Surg. 2001;71:684–693
   Google Scholar
• Bogă M, Islamoğlu F, Badak I, et al. The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting. Perfusion. 2000;15:143–150
   Google Scholar
• Hoffmann JN, Werdan K, Hartl WH, Jochum M, Faist E, Inthorn D. Hemofiltrate from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock. 1999;12:174–180
   Google Scholar
• Toft P, Kehler D, Brandslund I I, Tønnsen E. The immunological effects of continuous veno-venous hemodiafiltration in critically ill patients. Crit Care. 1999;3:159–165
   PubMedGoogle Scholar
• Watanabe T, Sakai Y, Mayumi T, et al. Effect of ultrafiltration during cardiopulmonary bypass for pediatric cardiac surgery. Artif Organs. 1998;22:1052–1055
   Google Scholar
• Wang W, Huang HM, Zhu DM, Chen H, Su ZK, Ding WX. Modified ultrafiltration in paediatric cardiopulmonary bypass. Perfusion. 1998;13:304–310
   Google Scholar
• Hoffmann JN, Faist E, Deppisch R, Hartl WH, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Contrib Nephrol. 1995;116:76–79
   Google Scholar
• Xie H, Ji D, Gong D, et al. Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J (Engl). 2003;116:549–553
   PubMed Web of Science ®Google Scholar
• Mariano F, Tetta C, Guida G, Triolo G, Camussi G. Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int. 2001;60:1598–1605
   PubMed Web of Science ®Google Scholar
• Reeves JH, Butt WW, Shann F, et al. Continuous plasma filtration in sepsis syndrome. Plasma filtration in Sepsis Study Group. Crit Care Med. 1999;27:2096–2104
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10:846–853
   PubMed Web of Science ®Google Scholar
• Clar A, Bowers MC, Larson DF. Derivation of sieving coefficients to determine the efficacy of the hemoconcentrator in removal of four inflammatory mediators produced during cardiopulmonary bypass. ASAIO J. 1997;43:163–170
   Google Scholar
• Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int. 1995;48:1563–1570
   PubMed Web of Science ®Google Scholar
• Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R, Nakatani T. Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome. Int J Mol Med. 2002;10:485–488
   Google Scholar
• Yonekawa C, Nakae H, Tajimi K, Asanuma Y. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artif Organs. 2005;29:324–328
   Google Scholar
• Tallman RD, Dumond M, Brown D. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion. 2002;17:111–115
   Google Scholar
• Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume hemofiltration in human septic shock. Intensive Care Med. 2001;27:978–986
   PubMed Web of Science ®Google Scholar
• Nishida O, Nakamura T, Kuriyama N, et al. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. Contrib Nephrol. 2011;173:172–181
   Google Scholar
• Schilder L, Nurmohamed SA, ter Wee PM, et al. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury. Cytokine. 2012;60:601–607
   Google Scholar
• Oishi K, Mimura-Kimura Y, Miyasho T, et al. Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis. Cytokine. 2013;61:84–89
   PubMed Web of Science ®Google Scholar
• Atan R, Crosbie D, Bellomo R. Techniques of extracorporeal cytokine removal: a systematic review of the literature. Blood Purif. 2012;33:88–100
   Google Scholar
• Atan R, Crosbie D, Bellomo R. Techniques of extracorporeal cytokine removal: a systematic review of the literature on animal experimental studies. Int J Artif Organs. 2013;36:149–158
   Google Scholar
• Brain M, Anderson M, Parkes S, Fowler P. Magnesium flux during continuous venous hemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc. 2012;14:274–282
   Google Scholar
• Brain M, Parkes S, Fowler P, Robertson I, Brown A. Calcium flux in continuous venovneous hemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc. 2011;13:72–81
   PubMed Web of Science ®Google Scholar